Historical Valuation
Dexcom Inc (DXCM) is now in the Undervalued zone, suggesting that its current forward PE ratio of 27.81 is considered Undervalued compared with the five-year average of 89.08. The fair price of Dexcom Inc (DXCM) is between 97.43 to 291.64 according to relative valuation methord. Compared to the current price of 70.10 USD , Dexcom Inc is Undervalued By 28.05%.
Relative Value
Fair Zone
97.43-291.64
Current Price：70.10
28.05%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Dexcom Inc (DXCM) has a current Price-to-Book (P/B) ratio of 9.52. Compared to its 3-year average P/B ratio of 16.92 , the current P/B ratio is approximately -43.73% higher. Relative to its 5-year average P/B ratio of 18.42, the current P/B ratio is about -48.32% higher. Dexcom Inc (DXCM) has a Forward Free Cash Flow (FCF) yield of approximately 4.09%. Compared to its 3-year average FCF yield of 1.70%, the current FCF yield is approximately 140.97% lower. Relative to its 5-year average FCF yield of 1.19% , the current FCF yield is about 243.89% lower.
P/B
Median3y
16.92
Median5y
18.42
FCF Yield
Median3y
1.70
Median5y
1.19
Competitors Valuation Multiple
AI Analysis for DXCM
The average P/S ratio for DXCM competitors is 4.83, providing a benchmark for relative valuation. Dexcom Inc Corp (DXCM.O) exhibits a P/S ratio of 5.13, which is 6.23% above the industry average. Given its robust revenue growth of 21.64%, this premium appears sustainable.
Performance Decomposition
AI Analysis for DXCM
1Y
3Y
5Y
Market capitalization of DXCM increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DXCM in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DXCM currently overvalued or undervalued?
Dexcom Inc (DXCM) is now in the Undervalued zone, suggesting that its current forward PE ratio of 27.81 is considered Undervalued compared with the five-year average of 89.08. The fair price of Dexcom Inc (DXCM) is between 97.43 to 291.64 according to relative valuation methord. Compared to the current price of 70.10 USD , Dexcom Inc is Undervalued By 28.05% .
What is Dexcom Inc (DXCM) fair value?
DXCM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Dexcom Inc (DXCM) is between 97.43 to 291.64 according to relative valuation methord.
How does DXCM's valuation metrics compare to the industry average?
The average P/S ratio for DXCM's competitors is 4.83, providing a benchmark for relative valuation. Dexcom Inc Corp (DXCM) exhibits a P/S ratio of 5.13, which is 6.23% above the industry average. Given its robust revenue growth of 21.64%, this premium appears sustainable.
What is the current P/B ratio for Dexcom Inc (DXCM) as of Jan 09 2026?
As of Jan 09 2026, Dexcom Inc (DXCM) has a P/B ratio of 9.52. This indicates that the market values DXCM at 9.52 times its book value.
What is the current FCF Yield for Dexcom Inc (DXCM) as of Jan 09 2026?
As of Jan 09 2026, Dexcom Inc (DXCM) has a FCF Yield of 4.09%. This means that for every dollar of Dexcom Inc’s market capitalization, the company generates 4.09 cents in free cash flow.
What is the current Forward P/E ratio for Dexcom Inc (DXCM) as of Jan 09 2026?
As of Jan 09 2026, Dexcom Inc (DXCM) has a Forward P/E ratio of 27.81. This means the market is willing to pay $27.81 for every dollar of Dexcom Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Dexcom Inc (DXCM) as of Jan 09 2026?
As of Jan 09 2026, Dexcom Inc (DXCM) has a Forward P/S ratio of 5.13. This means the market is valuing DXCM at $5.13 for every dollar of expected revenue over the next 12 months.